PortalPublikationenThe placebo and nocebo effects in functional urology

The placebo and nocebo effects in functional urology

Standard

The placebo and nocebo effects in functional urology. / Mostafaei, Hadi; Jilch, Sandra; Carlin, Greta Lisa; Mori, Keiichiro; Quhal, Fahad; Pradere, Benjamin; Laukhtina, Ekaterina; Schuettfort, Victor M; Aydh, Abdulmajeed; Sari Motlagh, Reza; Roehrborn, Claus G; Shariat, Shahrokh F; Hajebrahimi, Sakineh.

in: NAT REV UROL, Jahrgang 19, Nr. 3, 03.2022, S. 171-189.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Mostafaei, H, Jilch, S, Carlin, GL, Mori, K, Quhal, F, Pradere, B, Laukhtina, E, Schuettfort, VM, Aydh, A, Sari Motlagh, R, Roehrborn, CG, Shariat, SF & Hajebrahimi, S 2022, 'The placebo and nocebo effects in functional urology', NAT REV UROL, Jg. 19, Nr. 3, S. 171-189. https://doi.org/10.1038/s41585-021-00545-2

APA

Mostafaei, H., Jilch, S., Carlin, G. L., Mori, K., Quhal, F., Pradere, B., Laukhtina, E., Schuettfort, V. M., Aydh, A., Sari Motlagh, R., Roehrborn, C. G., Shariat, S. F., & Hajebrahimi, S. (2022). The placebo and nocebo effects in functional urology. NAT REV UROL, 19(3), 171-189. https://doi.org/10.1038/s41585-021-00545-2

Vancouver

Mostafaei H, Jilch S, Carlin GL, Mori K, Quhal F, Pradere B et al. The placebo and nocebo effects in functional urology. NAT REV UROL. 2022 Mär;19(3):171-189. https://doi.org/10.1038/s41585-021-00545-2

Bibtex

@article{a7784bc854d74ecbb43cd4e78707cae7,
title = "The placebo and nocebo effects in functional urology",
abstract = "A placebo is an inert substance normally used in clinical trials for comparison with an active substance. However, a placebo has been shown to have an effect on its own; commonly known as the placebo effect. A placebo is an essential component in the design of conclusive clinical trials but has itself become the focus of intense research. The placebo effect is partly the result of positive expectations of the recipient on the state of health. Conversely, a nocebo effect is when negative expectations from a substance lead to poor treatment outcomes and/or adverse events. Randomized controlled trials in functional urology have demonstrated the importance of the placebo and nocebo effects across different diseases such as overactive bladder, urinary incontinence, lower urinary tract symptoms and interstitial cystitis/painful bladder syndrome, as well as male and female sexual dysfunction. Understanding the true nature of the placebo-nocebo complex and the scope of its effect in functional urology could help urologists to maximize the positive effects of this phenomenon while minimizing its potentially negative effects.",
author = "Hadi Mostafaei and Sandra Jilch and Carlin, {Greta Lisa} and Keiichiro Mori and Fahad Quhal and Benjamin Pradere and Ekaterina Laukhtina and Schuettfort, {Victor M} and Abdulmajeed Aydh and {Sari Motlagh}, Reza and Roehrborn, {Claus G} and Shariat, {Shahrokh F} and Sakineh Hajebrahimi",
note = "{\textcopyright} 2021. Springer Nature Limited.",
year = "2022",
month = mar,
doi = "10.1038/s41585-021-00545-2",
language = "English",
volume = "19",
pages = "171--189",
journal = "NAT REV UROL",
issn = "1759-4812",
publisher = "NATURE PUBLISHING GROUP",
number = "3",

}

RIS

TY - JOUR

T1 - The placebo and nocebo effects in functional urology

AU - Mostafaei, Hadi

AU - Jilch, Sandra

AU - Carlin, Greta Lisa

AU - Mori, Keiichiro

AU - Quhal, Fahad

AU - Pradere, Benjamin

AU - Laukhtina, Ekaterina

AU - Schuettfort, Victor M

AU - Aydh, Abdulmajeed

AU - Sari Motlagh, Reza

AU - Roehrborn, Claus G

AU - Shariat, Shahrokh F

AU - Hajebrahimi, Sakineh

N1 - © 2021. Springer Nature Limited.

PY - 2022/3

Y1 - 2022/3

N2 - A placebo is an inert substance normally used in clinical trials for comparison with an active substance. However, a placebo has been shown to have an effect on its own; commonly known as the placebo effect. A placebo is an essential component in the design of conclusive clinical trials but has itself become the focus of intense research. The placebo effect is partly the result of positive expectations of the recipient on the state of health. Conversely, a nocebo effect is when negative expectations from a substance lead to poor treatment outcomes and/or adverse events. Randomized controlled trials in functional urology have demonstrated the importance of the placebo and nocebo effects across different diseases such as overactive bladder, urinary incontinence, lower urinary tract symptoms and interstitial cystitis/painful bladder syndrome, as well as male and female sexual dysfunction. Understanding the true nature of the placebo-nocebo complex and the scope of its effect in functional urology could help urologists to maximize the positive effects of this phenomenon while minimizing its potentially negative effects.

AB - A placebo is an inert substance normally used in clinical trials for comparison with an active substance. However, a placebo has been shown to have an effect on its own; commonly known as the placebo effect. A placebo is an essential component in the design of conclusive clinical trials but has itself become the focus of intense research. The placebo effect is partly the result of positive expectations of the recipient on the state of health. Conversely, a nocebo effect is when negative expectations from a substance lead to poor treatment outcomes and/or adverse events. Randomized controlled trials in functional urology have demonstrated the importance of the placebo and nocebo effects across different diseases such as overactive bladder, urinary incontinence, lower urinary tract symptoms and interstitial cystitis/painful bladder syndrome, as well as male and female sexual dysfunction. Understanding the true nature of the placebo-nocebo complex and the scope of its effect in functional urology could help urologists to maximize the positive effects of this phenomenon while minimizing its potentially negative effects.

U2 - 10.1038/s41585-021-00545-2

DO - 10.1038/s41585-021-00545-2

M3 - SCORING: Review article

C2 - 34949831

VL - 19

SP - 171

EP - 189

JO - NAT REV UROL

JF - NAT REV UROL

SN - 1759-4812

IS - 3

ER -